RHOA (G17V) mutation is observed in 50–70% of AITL, which acts as a dominant-negative signaling protein, increasing cell proliferation by activation of AKT [10, 19, 20, 34]. Here, AKT1 is linked to angioimmunoblastic T-cell lymphoma.